Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Background: The adjuvant short course 9-week trastuzumab combination therapy for human epidermal receptor 2 positive breast cancer patients may often be considered as a cost-effective and safe option and has important implications for the Indian subcontinent as well as other developing countries. Ho...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017-01-01
|
| Schriftenreihe: | South Asian Journal of Cancer |
| Schlagworte: | |
| Online-Zugang: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=2;spage=47;epage=50;aulast=Hingmire |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|